Tallahassee, FL, United States of America

Eric Holmes

This inventor holds 10 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: The Florida State University Research Foundation, Inc.. Active years: 2018-2026.

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 90.0

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

10 out of 852

The Florida State University Research Foundation, Inc.

patents

Years Active: 2018-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12667558 - TREATMENT OF HUMAN CORONAVIRUS INFECTIONS USING ALPHA-GLUCOSIDASE GLYCOPROTEIN PROCESSING INHIBITORS (2026-06-30),

2. 12427126 - Niclosamide formulations and methods of use (2025-09-30),

3. 12161611 - Niclosamide formulations and methods of use (2024-12-10),

4. 11771668 - Niclosamide formulations and methods of use (2023-10-03),

5. 11518762 - Large scale purification of castanospermine (2022-12-06),

6. 11369592 - Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors (2022-06-28),

7. 10562978 - Methods using antibodies specific for 4,6-diamino-5-(formamido)pyrimidine (2020-02-18),

8. 10561642 - Treatment of Zika virus infections using alpha-glucosidase inhibitors (2020-02-18),

9. 10328061 - Treatment of Zika virus infections using alpha-glucosidase inhibitors (2019-06-25),

10. 9884920 - Antibodies specific for 4,6-diamino-5-(formamido)pyrimidine and uses thereof (2018-02-06),

Title: Innovations of Eric Holmes in Niclosamide Formulations

Introduction

Eric Holmes is an accomplished inventor based in Tallahassee, Florida. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on niclosamide compounds. With a total of nine patents to his name, Holmes has been at the forefront of developing innovative solutions for medical applications.

Latest Patents

One of Eric Holmes' latest patents involves niclosamide formulations and methods of use. This invention concerns compositions that include at least one niclosamide compound, such as niclosamide or a pharmaceutically acceptable salt thereof, along with a permeability enhancer like glycerol or dimethylpalmityl-ammonio propanesulfonate (PPS). The advantage of this formulation is that the niclosamide compound can be transported across a Caco-2 cell membrane by at least 150% compared to the amount that can be transported without the permeability enhancer. This innovation also includes oral dosage forms and methods for delivering niclosamide compounds, particularly for the treatment or prevention of human coronavirus infections.

Career Highlights

Eric Holmes is affiliated with the Florida State University Research Foundation, Inc. His work has been instrumental in advancing the understanding and application of niclosamide in therapeutic contexts. His dedication to research and innovation has led to significant advancements in the pharmaceutical industry.

Collaborations

Holmes has collaborated with notable colleagues such as Gary Ostrander and Geoffrey Stuart Dow. These partnerships have contributed to the successful development of his patented formulations and have enhanced the impact of his research.

Conclusion

Eric Holmes is a prominent inventor whose work in niclosamide formulations has the potential to significantly impact medical treatments. His innovative approaches and collaborations continue to drive advancements in pharmaceutical science.